Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune multisystem disorder with a wide range of clinical and laboratory manifestations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Tsokos GC. Overview of cellular immune function in systemic lupus erythematosus. In: Lahita G, editor. Systemic lupus erythematosus. Amsterdam: Elsevier; 2004. p. 29–92.
Young RL. Changes in immune function with age. Rheum Dis Clin North Am. 2000;26(3):455–73.
Kammer GM, Mishra N. Systemic lupus erythematosus in the elderly. Rheum Dis Clin North Am. 2000;26:475–92.
Song L, Ho Kim Y, Chopra RK, et al. Age-related effects in T-cell activation and proliferation. Exp Gerontol. 1993;28:313–21.
Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39:687–99.
Gladman DD, Urowitz MB. Connective tissue disorders. Systemic lupus erythematosus. Clinical features. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby; 1994. p. 6.2.1–20.
Maddison PJ. Systemic lupus erythematosus in the elderly. J Rheumatol. 1987;14 Suppl 13:182–7.
Formiga F, Moga I, Pac M, et al. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. Lupus. 1999;8:462–5.
Pu SJ, Luo SF, Wu YJJ, et al. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus. 2000;9:96–100.
Weitzel KW. Treatment of lupus erythematosus. www.cop.ufl.edu/safezone/root/programs/cepm/Lupus/Article.pdf.
Baker SB, Rovira JR, Campion EW, et al. Late onset systemic lupus erythematosus. Am J Med. 1979;66:727–32.
Padovan M, Govoni M, Castellino G, et al. Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages. Rheumatol Int. 2007;27:735–41.
Bertoli AM, Alarcon GS, Calvo-Alen J, et al. Systemic lupus erythematosus in a Multiethnic US Cohort. Arthritis Rheum. 2006;5:1580–7.
Cattogio LJ, Skinner RP, Smith G, et al. Systemic lupus erythematosus in the elderly. Clinical and serological characteristics. J Rheumatol. 1984;11:175–81.
Ramos-Casals M, Garcia-Carraso M, Brito MP, et al. Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly. Lupus. 2003;12:341–55.
Wilson HA, Hamilton ME, Spyker DA, et al. Age influences the clinical and serological expression of systemic lupus erythematosus. Arthritis Rheum. 1981;24:1230–5.
Mak SK, Lam EKM, Wong AKM. Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus. 1998;7:23–8.
Koh MT, Boye ML. Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol. 1994;21:1463–7.
Ho CK, Mok CH, Lau CH, et al. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis. 1998;57:437–40.
Tuchyňová A, Rovenský J, Lukáč J. Systémový lupus erythematosus vo vyššom veku: retrospektívna štúdia. Čes Revmatol. 1998;6:123–6 [In Slovak].
Maddison P, Farewell V, Isenberg D, et al. The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol. 2002;29:913–7.
Belostocki KB, Paget SA. Inflammatory rheumatologic disorders in the elderly. Postgrad Med. 2002;111:72–83.
Cervera K, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine. 1993;72:113–24.
Ward MM, Polisson RP. A meta-analysis of the clinical manifestation of older-onset systemic lupus erythematosus. Arthritis Rheum. 1989;32:1226–32.
Boddaert J, Huong DL, Amoura Z, et al. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore). 2004;83:348–59.
Tan M, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum. 1982;25:1271–7.
Rovenský J, Lukáč J, Cebecauer L, et al. Lupus erythematosus indukovaný liekmi. In: Rovenský J, Pavelka K, editors. Klinická revmatologie. Martin: Osveta; 2000. p. 301–5 [In slovak].
Fischer-Betz R, Schneider M. Antimalariamittel. Therapieoption für jeden Lupus-Patienten?! [Antimalarials. A treatment option for every lupus patient?!] Z Rheumatol. 2009;68:6–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tuchyňová, A., Rovenský, J. (2017). Systemic Lupus Erythematosus. In: Rovenský, J. (eds) Gerontorheumatology. Springer, Cham. https://doi.org/10.1007/978-3-319-31169-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-31169-2_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31167-8
Online ISBN: 978-3-319-31169-2
eBook Packages: MedicineMedicine (R0)